MCL1 inhibitor

JP2025163130APending Publication Date: 2025-10-28GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2025128356
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-11-12
Filing Date
2025-07-31
Publication Date
2025-10-28

Smart Images

  • Figure 2025163130000001
    Figure 2025163130000001
  • Figure 2025163130000002
    Figure 2025163130000002
  • Figure 2025163130000003
    Figure 2025163130000003
Patent Text Reader

Abstract

To provide a novel compound that inhibits MCL1.SOLUTION: The present application generally relates to specific compounds that inhibit MCL1, pharmaceutical compositions comprising the compounds, uses of the compounds for treating cancer, and methods for producing the compounds. In one embodiment, the present application relates to a compound of formula (I) and a pharmaceutical composition usable for treating cancer.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art